Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Sylvie Bonvalot: Grant from INCA (the French National Cancer Institute). Axel Le Cesne: Honoraria (fees) from Deciphera, Pharmamar, and Bayer. Jean-Yves Blay: NETSARC+; LYRICAN, and LYRICAN + (all funded by the French National Cancer Institute). Sarah Watson: Consultancy work for Deciphera and Amgen. Philippe Anract: Consultant for Medcata International and Amplitude, and attended scientific meetings for Sanofi and Grunenthal. Intellectual property, patents and copyrights: Serf. orthopedic prosthesis Nathalie Cozic, Nicolas Penel, Magali Fau, Christine Chevreau, Denis Waast, Valérie Laurence, Florence Duffaud, François Gouin, Sophie Taieb, Michèle Kind, and Laurent Lam have no disclosures to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bonvalot, S., Cozic, N., Le Cesne, A. et al. ASO Visual Abstract: Initial Active Surveillance Strategy for Patients with Peripheral Sporadic Primary Desmoid-Type Fibromatosis: A Multicentric Phase II Observational Trial. Ann Surg Oncol 30, 8671–8672 (2023). https://doi.org/10.1245/s10434-023-14396-1
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-14396-1